Skip to main content

Table 4 Application of the Strongest Eczema Case Definitions to the CPCSSN Repository N = 689,301 patients

From: Validation of a primary care electronic medical records case definition for eczema: retrospective cross-sectional study

Case definition

Prevalence n(%, 95%CI)

Female patient, n(%)

Patient age, mean(SD)

Eczema medication n (%)

Patients with an allergy n (%)

Patients with asthma n(%)

Patients with rhinitis n(%)

Case definition 1

104,354 (15.1%, 15.05–15.22%)

65,085 (62.4%)

53.9 (19.9)

27,885 (26.7%)

14,948 (14.3%)

18,973 (18.2%)

11,151 (10.7%)

Case definition 7

5569 (0.8%, 0.79–0.83%)

3479 (62.5%)

48.9 (20.3)

1620 (29.1%)

447 (8.0%)

1228 (22.1%)

786 (14.1%)

Case definition 13

28,762 (4.2%, 4.13–4.22%)

18,240 (63.4%)

51.9 (20.0)

8452 (29.4%)

2892 (10.1%)

5426 (18.9%)

4208 (14.6%)

Case definition 14

97,980 (14.2%, 14.13–14.3%)

61,258 (62.5%)

53.9 (19.9)

26,301 (26.8%)

14,260 (14.6%)

17,998 (18.4%)

10,429 (10.6%)

Case definition 17

56,171 (8.2%, 8.08–8.21%)

35,434 (63.1%)

53.4 (20.1)

15,275 (27.2%)

7504 (13.4%)

11,007 (19.6%)

7167 (12.8%)

Case definition 23

67,416 (9.8%, 9.71–9.85%)

42,467 (63.0%)

52.3 (20.0)

26,301 (39.0%) [1]

14,260 (21.2%) 1

17,998 (26.7%) 1

10,429 (15.5%) 1

Patients not captured in an eczema case definition

584,538 (84.8%)

322,481 (55.2%)

52.0 (19.3)

55,506 (9.5%)

84,878 (14.5%)

64,811 (11.1%)

31,863 (5.5%)

  1. 1medication, allergy, asthma and rhinitis diagnosis are included in the case definition
  2. Boldface font indicated the variable was significant at p-value > 0.05
  3. 95%CI: 95% confidence intervals